Skip to content

Peginterferon beta-1a

Plegridy (peginterferon beta-1a) is a protein pharmaceutical. Peginterferon beta-1a was first approved as Plegridy on 2014-07-17. It is used to treat multiple sclerosis in the USA. It has been approved in Europe to treat multiple sclerosis.
Trade Name Plegridy
Common Name Peginterferon beta-1a
Indication multiple sclerosis
Drug Class Pegylated compounds
Peginterferon beta-1a
Get full access now